GL1X · GenesisL1 explorer

UniProt P30419

Glycylpeptide N-tetradecanoyltransferase 1 (P30419)

Glycylpeptide N-tetradecanoyltransferase 1 (UniProt P30419), EC 2.3.1.97: 48 experimental structures on GenesisL1, 16 ligands bound, 41 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P30419
Protein
Glycylpeptide N-tetradecanoyltransferase 1
EC
2.3.1.97
Experimental structures
48
Predicted models
0
Ligands
16
Pockets
41 · 7 records with a druggable one

Structures

48 records of P30419 in the MolNFT archive: 48 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1RXTCrystal structure of human myristoyl-CoA:protein N-myristoyltransferase.x-ray diffractionA, B, C, D——
1RXTCrystal structure of human myristoyl-COA:PROTEIN N- myristoyltransferase.x-ray diffractionA, B, C, D——
3IU1Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoAx-ray diffractionA, B——
3IU1Crystal structure of human type-I N-myristoyltransferase with bound myristoyl-CoAx-ray diffractionA, B——
3IU2Crystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor…x-ray diffractionA, B——
3IU2Crystal structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor…x-ray diffractionA, B——
3IWECrystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor…x-ray diffractionA, B——
3IWECrystal structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor…x-ray diffractionA, B——
3JTKCrystal Structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor…x-ray diffractionA, B——
3JTKCrystal structure of human type-I N-myristoyltransferase with bound myristoyl-CoA and inhibitor…x-ray diffractionA, B——
4C2YHuman N-myristoyltransferase (NMT1) with Myristoyl-CoA co-factorx-ray diffractionA, B——
4C2YHuman N-myristoyltransferase (NMT1) with myristoyl-CoA co-factorx-ray diffractionA, B——
4C2ZHuman N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor boundx-ray diffractionA, B——
4C2ZHuman N-myristoyltransferase (NMT1) with myristoyl-CoA and inhibitor boundx-ray diffractionA, B——
5MU6Human N-myristoyltransferase (NMT1) with myristoyl-CoA and imp-1088 inhibitor boundx-ray diffractionA, BMYA, MG, KFK—
5NPQHuman N-myristoyltransferase 1 (MNT1) with Myristoyl-CoA analogue X10 boundx-ray diffractionA, B94Q, MG—
5NPQHuman N-myristoyltransferase 1 (MNT1) with myristoyl-CoA analogue X10 boundx-ray diffractionA, B94Q, MG—
5O6HHuman NMT1 in complex with myristoyl-CoA and inhibitor IMP-917x-ray diffractionA, BMYA, PO4, 9M2, MG—
5O6HHuman NMT1 in complex with myristoyl-CoA and inhibitor imp-917x-ray diffractionA, BMYA, PO4, 9M2, MG—
5O6JHuman NMT1 in complex with myristoyl-CoA and inhibitor IMP-1031x-ray diffractionA, BMYA, PO4, MG, 9M85 (best 0.81)
5O6JHuman NMT1 in complex with myristoyl-CoA and inhibitor imp-1031x-ray diffractionA, BMYA, PO4, MG, 9M8—
5O9SHSNMT1 in complex with CoA and myristoylated-gksnsklk octapeptidex-ray diffractionA, BCL, MYR—
5O9THSNMT1 in complex with CoA and acetylated-ncfskpk peptidex-ray diffractionA, BMYA, CL—
5O9UHSNMT1 in complex with CoA and myristoylated-gcsvskkk octapeptidex-ray diffractionA, BCOA, MYR—
5O9VHSNMT1 in complex with CoA and myristoylated-ggcfskpk octapeptidex-ray diffractionA, BCOA, CL, MYR—
5UUTN-myristoyltransferase 1 (nmt) bound to myristoyl-CoAx-ray diffractionA, BMYA—
6EHJHuman N-myristoyltransferase (NMT1) with myristoyl-CoA and peptide boundx-ray diffractionA, BMYA, MYR, COA—
6F56Mutant of Human N-myristoyltransferase with bound myristoyl-CoAx-ray diffractionA, B, C, DMYA, MG—
6F56Mutant of human N-myristoyltransferase with bound myristoyl-CoAx-ray diffractionA, B, C, DMYA, MG—
6FZ2Human N-myristoyltransferase (NMT1) with myristoyl-CoA and inhibitor boundx-ray diffractionA, B31A, MYA, MG—
6FZ3Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor boundx-ray diffractionA, BEBK, MYA, MG5 (best 0.78)
6FZ3Human N-myristoyltransferase (NMT1) with myristoyl-CoA and inhibitor boundx-ray diffractionA, BEBK, MYA, MG—
6FZ5Human N-myristoyltransferase (NMT1) with Myristoyl-CoA and inhibitor boundx-ray diffractionA, BBXN, MYA, MG5 (best 0.78)
6FZ5Human N-myristoyltransferase (NMT1) with myristoyl-CoA and inhibitor boundx-ray diffractionA, BBXN, MYA, MG—
6PAVStructure of Human NMT1 with products CoA and myristoyl-lysine peptide with acetylated N-terminusx-ray diffractionB, ACOA, MYR—
6PAVStructure of human NMT1 with products CoA and myristoyl-lysine peptide with acetylated N-terminusx-ray diffractionB, AACE, COA, MYR—
6QRMHSNMT1 in complex with both myrcoa and gncfskrraa substratesx-ray diffractionA, BCOA, CL, MYA, MYR—
6SJZHSNMT1 in complex with both myrcoa and acetylated-gncfskpr substratesx-ray diffractionA, BACE, MYA, CL—
6SK2HsNMT1 in complex with both MyrCoA and Acetylated-GKSFSKPR peptide reveals N-terminal Lysine…x-ray diffractionA, BCOA, MYA, MYR8 (best 0.78)
6SK2HSNMT1 in complex with both myrcoa and acetylated-gksfskpr peptide reveals N-terminal lysine…x-ray diffractionA, BACE, COA, MYA, MYR—
6SK3C-terminal HSNMT1 DELTAC3 truncation in complex with both myrcoa and gncfskpr substratesx-ray diffractionA, BMYA, MG—
6SK8DELTAC3 C-terminal truncation of HSNMT1 in complex with myrcoa and gdcfskpr substratesx-ray diffractionA, BMYA, CL—
6SKJDELTAC2 C-terminal truncation of HSNMT1 in complex with myrcoa and gncfskpr substratesx-ray diffractionA, BCOA, MG, MYA, MYR—
7RK3Crystal structure of human N-myristoyltransferase 1 fragment (residues 109-496) bound to diacylated…x-ray diffractionA4PS, MYR, 6NA—
8Q26HsNMT1 in complex with both MyrCoA and GNCFSKPR inhibitor peptidex-ray diffractionA, BCOA, CL, MG, MYR6 (best 0.76)
8Q2ZHsNMT1 in complex with both MyrCoA and GNLLSKFR peptidex-ray diffractionA, BCOA, CL, MG, MYR6 (best 0.77)
8Q3THsNMT1 in complex with both MyrCoA and GNCFSKPRVPTK inhibitor peptidex-ray diffractionA, BCOA, CL, MYR6 (best 0.77)
P30419AlphaFold monomer V2.0 prediction for glycylpeptide N-tetradecanoyltransferase 1 (P30419)———

Ligands

  • MYA · Tetradecanoyl-coa · in 22 records
  • MG · Magnesium ion · in 18 records
  • MYR · Myristic acid · in 14 records
  • COA · Coenzyme A · in 12 records
  • CL · Chloride ion · in 9 records
  • PO4 · Phosphate ion · in 4 records
  • ACE · Acetyl group · in 3 records
  • 94Q · ~{S}-[2-[3-[[(2~{S})-4-[[[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxy-3,3-dimethyl-2-oxidanyl-butanoyl]amino]propanoylamino]ethyl] 9-(3-but-3-ynyl-1,2-diazirin-3-yl)nonanethioate · in 2 records
  • 9M2 · 1-[5-[4-fluoranyl-2-[2-(1,3,5-trimethylpyrazol-4-yl)ethoxy]phenyl]-2~{H}-indazol-3-yl]-~{N},~{N}-dimethyl-methanamine · in 2 records
  • 9M8 · 1-[5-[3-fluoranyl-2-[2-(1,3,5-trimethylpyrazol-4-yl) ethoxy]phenyl]-1-methyl-indazol-3-yl]-~{N},~{N}-dimethyl-methanamine · in 2 records
  • BXN · 4-[3-[(8~{A}~{R})-3,4,6,7,8,8~{A}-hexahydro-1~{H}-pyrrolo[1,2-a]pyrazin-2-yl]propyl]-2,6-bis(chloranyl)-~{N}-methyl-~{N}-(1,3,5-trimethylpyrazol-4-yl) benzenesulfonamide · in 2 records
  • EBK · 2,6-bis(chloranyl)-4-[2-(4-methylpiperazin-1-yl) pyridin-4-yl]-~{N}-(1,3,5-trimethylpyrazol-4-yl) benzenesulfonamide · in 2 records
  • 31A · N-[2-(3-methoxyphenyl)ethanimidoyl]-2-piperidin-4-yloxy-benzamide · in 1 record
  • 4PS · 4'-diphospho pantetheine · in 1 record
  • 6NA · Hexanoic acid · in 1 record
  • KFK · 1-[5-[3,4-bis(fluoranyl)-2-[2-(1,3,5-trimethylpyrazol-4-yl)ethoxy]phenyl]-1-methyl-indazol-3-yl]-~{N},~{N}-dimethyl-methanamine · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.